Hybrid liposome–erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation

Liposome, a widely used drug delivery system (DDS), still shows several disadvantages such as dominant clearance by liver and poor target organ deposition. To overcome the drawbacks of liposomes, we developed a novel red blood cell (RBC)–liposome combined DDS to modulate the tumor accumulation and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kehui, Xu, Yingcan, Zhong, Rui, Li, Wanjing, Wang, Hong, Wong, Yee Shan, Venkatraman, Subramanian, Liu, Jiaxin, Cao, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224802/
https://www.ncbi.nlm.nih.gov/pubmed/37250975
http://dx.doi.org/10.1093/rb/rbad045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224802/
https://www.ncbi.nlm.nih.gov/pubmed/37250975
http://dx.doi.org/10.1093/rb/rbad045

Ejemplares similares